VU UNIVERSITY MEDICAL CENTER.
Blood. 2016 Mar 24;127(12):1521-2. doi: 10.1182/blood-2016-01-692111.
In this issue of Blood, Barrington et al present the analyses of centrally reviewed positron emission tomography-computed tomography (PET-CT) used for staging and response monitoring after 2 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) to guide treatment modification in a large prospective clinical trial in Hodgkin lymphoma (HL) (Response-Adapted Therapy in Advanced Hodgkin Lymphoma [RATHL]).
在本期《Blood》中，Barrington 等人报告了使用多柔比星、博来霉素、长春碱、达卡巴嗪（ABVD）治疗 2 周期后，为指导霍奇金淋巴瘤（HL）大型前瞻性临床试验（适应性治疗晚期霍奇金淋巴瘤 [RATHL]）中的治疗修改而进行的中心审查正电子发射断层扫描-计算机断层扫描（PET-CT）的分析。
